Suppr超能文献

口服免疫后的全身耐受性和分泌性免疫

Systemic tolerance and secretory immunity after oral immunization.

作者信息

Challacombe S J, Tomasi T B

出版信息

J Exp Med. 1980 Dec 1;152(6):1459-72. doi: 10.1084/jem.152.6.1459.

Abstract

Diminished systemic immune reaction after ingestion of antigen has been reported in several animal models. Conversely, it has been reported recently that oral immunization may lead to the production of secretory antibodies. To determine whether these events could occur concurrently, CBA/J mice were immunized intragastrically with varying doses of ovalbumin (OVA) and Streptococcus mutans. After 7 d, the animals were challenged systemically with antigen in complete adjuvant and 8 d later serum and saliva taken, and the draining lymph nodes assayed for a proliferative response. Intragastric doses of 1 mg OVA or 10(9) S. mutans led to significant suppression of the proliferative response, and intragastric doses of 10 mg OVA or 2.5 X 10(9) S. mutans led to the production of detectable salivary antibodies using hemagglutination. Serum antibodies were not detected after intragastric administration of OVA or S. mutans. Suppression of the proliferative response could be detected from 2-60 d after intragastric administration of OVA, and 2-21 d after S. mutans. Prior intragastric immunization with heterologous antigens did not suppress the response to OVA or S. mutans. Transfer of 40 X 10(6) mesenteric lymph node cells from mice given 20 mg OVA or 10(9) S. mutans led to suppression of the proliferative response in syngeneic recipients. Salivary antibodies wer removed by absorption with anti-IgA, but not anti-IgG or IgM, indicating that they were of the IgA class. It appears that intragastric administration of soluble or particulate antigens in mice may lead to the concurrent induction of salivary antibodies and systemic suppression.

摘要

在多种动物模型中均有报道,摄入抗原后全身免疫反应会减弱。相反,最近有报道称口服免疫可能会导致分泌性抗体的产生。为了确定这些情况是否会同时发生,用不同剂量的卵清蛋白(OVA)和变形链球菌对CBA/J小鼠进行胃内免疫。7天后,用完全佐剂中的抗原对动物进行全身攻击,8天后采集血清和唾液,并检测引流淋巴结的增殖反应。胃内给予1mg OVA或10⁹变形链球菌可显著抑制增殖反应,胃内给予10mg OVA或2.5×10⁹变形链球菌可通过血凝反应检测到唾液抗体的产生。胃内给予OVA或变形链球菌后未检测到血清抗体。胃内给予OVA后2至60天以及变形链球菌后2至21天可检测到增殖反应受到抑制。预先用异源抗原进行胃内免疫不会抑制对OVA或变形链球菌的反应。将来自给予20mg OVA或10⁹变形链球菌的小鼠的40×10⁶个肠系膜淋巴结细胞转移,可导致同基因受体的增殖反应受到抑制。唾液抗体可被抗IgA吸收去除,但不能被抗IgG或IgM吸收去除,这表明它们属于IgA类。看来,在小鼠中胃内给予可溶性或颗粒性抗原可能会同时诱导唾液抗体和全身抑制。

相似文献

引用本文的文献

2
Murine models for mucosal tolerance in allergy.用于过敏的黏膜耐受的鼠类模型。
Semin Immunol. 2017 Apr;30:12-27. doi: 10.1016/j.smim.2017.07.007. Epub 2017 Aug 12.
7
Tolerizing allergic responses in the lung.在肺部诱导过敏反应。
Mucosal Immunol. 2010 Jul;3(4):334-44. doi: 10.1038/mi.2010.19. Epub 2010 May 26.

本文引用的文献

2
Oral tolerance.口服耐受
Transplantation. 1980 May;29(5):353-6. doi: 10.1097/00007890-198005000-00001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验